-
Establishing Robust and Adaptive Willingness-to-Pay Thresholds for Taiwan's National Health Insurance: A Case Study of Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
The Incidence Mortality and Survival of Malignant Chondrosarcoma in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2000-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
AI Models for Predicting Clinical Trial Success: Capabilities and Risks of Pattern-Driven Approaches
Sep 9, 2025, 16:22 PM -
Pain and Fatigue Assessment and Evaluation in Oncology Trials
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Inclisiran for the Management of Patients With Atherosclerotic Cardiovascular Disease in India: A Multipayer Analysis
Sep 9, 2025, 16:22 PM -
The Importance and Recognition of Hypo and Hyperkalemia in Prehospital Care
Sep 9, 2025, 16:22 PM -
Statistical Analysis of Health Technology Assessment Outcomes in Oncology: An Analysis of Key Clinical Value Drivers in Germany and France
Sep 9, 2025, 16:22 PM -
Time to and Time in Better Health States With Sotatercept for Pulmonary Arterial Hypertension: A Modeling Study
Sep 9, 2025, 16:22 PM -
Systematic Literature Review of Artificial Intelligence-Based Models Predicting COPD Exacerbations
Sep 9, 2025, 16:22 PM -
Bridging Systemic Access Gaps for Cancer Medicines: A Policy Perspective From the Republic of Moldova
Sep 9, 2025, 16:22 PM -
HTA Requirements for Medical Technologies in Germany
Sep 9, 2025, 16:22 PM -
Structural Uncertainty (SU) in Model-Based Economics Appraisal (MBEA): A Document Review of the French National Authority for Health (HAS)
Sep 9, 2025, 16:22 PM -
Is There Sufficient Economic Evidence for Reimbursing Behavioral Interventions? A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Potential Public Health Benefits of Recombinant Influenza Vaccines in Older Adults in England and Wales
Sep 9, 2025, 16:22 PM -
Simulating Patient Journeys in Heart Failure to Optimize Treatment Pathways: An Agent-Based Modeling Study
Sep 9, 2025, 16:22 PM -
Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib
Sep 9, 2025, 16:22 PM -
CAR-NK Cell Therapy for Ovarian Cancer Treatment in the First Relapse: Assessing Conditions Needed for Cost-Effectiveness in the Netherlands Using Early Health-Economic Modeling
Sep 9, 2025, 16:22 PM -
Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body: Improvements in Patient-Reported Outcomes and Quality of Life
Sep 9, 2025, 16:22 PM -
Impacts of Patient-Centered Collaboration: Application of a Continuous Engagement Plan Across Multiple Phases of the Insights and Patient Experiences With Cardiovascular Disease (IPEC) Initiative
Sep 9, 2025, 16:22 PM -
The Impact of the COVID-19 Pandemic on the Performance of the Hospital Care System in Romania as Measured Using the Diagnosis-Related Groups (DRGs) Financing Technique
Sep 9, 2025, 16:22 PM
